TransCelerate BioPharma Inc

See the following -

ACRO Establishing CRO Forum To Interact With TransCelerate BioPharma Inc.

Press Release | Association of Clinical Research Organizations | October 27, 2014

The Association of Clinical Research Organizations today announced plans to constitute a CRO Forum in order to provide a formal mechanism for the CRO industry to furnish input into the work of TransCelerate BioPharma Inc. The CRO Forum, expected to commence operation in January 2015, is open to all CROs and participation is included as a benefit of ACRO membership...

Read More »

DIA 2014 50th Annual Meeting To Highlight TransCelerate BioPharma Collaboration

Press Release | DIA, TransCelerate | May 6, 2014

Industry leaders in R&D will examine accomplishments, progress and 2014 line extensions. Susan Cantrell, senior vice president and managing director for DIA Americas, will chair the panel discussion “Collaboration in R&D: What’s New for TransCelerate BioPharma?” during DIA’s 2014 50th Annual Meeting at the San Diego Convention Center from June 15 to 19...

Read More »

Medidata And TransCelerate BioPharma Inc. Announce Joint Initiative

Press Release | Medidata, TransCelerate BioPharma Inc. | May 20, 2014

Collaboration to Explore Key Components of Recommended Risk-Based Monitoring Methodology

Read More »

TransCelerate BioPharma Inc. Releases Recommended Approach For Protecting Personal Data In Clinical Study Reports

Press Release | TransCelerate BioPharma Inc. | September 2, 2014

TransCelerate BioPharma Inc. ("TransCelerate") today announced that it has developed a recommended approach for protecting personal data in Clinical Study Reports (CSRs) that are shared with researchers, patients and others. The document describes an approach to apply when redacting or removing personal information from CSRs and other related clinical trial documents...

Read More »

TransCelerate Selects Cognizant To Develop A Clinical Trials Collaboration Platform

Press Release | TransCelerate BioPharma Inc., Cognizant | July 24, 2014

Cognizant (NASDAQ: CTSH) today announced that it has been selected by TransCelerate BioPharma Inc., a non-profit organization with membership representation from 19 major pharmaceutical companies, to develop a first-of-its-kind, subscription-based platform that will transform the way clinical sites collaborate with pharmaceutical companies on clinical trials...

Read More »